INDV
Indivior
$38.06
▼ -0.89%
−$0.34
NYSE · Health Care · Health Care
Indivior
INDV · NYSE · Health Care · Health Care
$38.06
▼ -0.89% · −$0.34 today
fundamentals84.4 /100 vs peers
strong
Revenue growth (TTM)10.3
26% below Sector 5Y avg avgSector 5Y avg: 14.0
EPS growth (TTM)998.2
8550% above Sector 5Y avg avg · favorableSector 5Y avg: 11.5
EPS forecast (5Y)19.1
34% above Sector fwd avg avg · favorableSector fwd avg: 14.3
EPS next year9.2
solid pace
EPS growth (Q/Q)83.5
strong pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| INDVIndivior | $4.50B | 19.5 | -0.3% | 84 |
| LLYEli Lilly and Company | $1.14T | 43.5 | +47.4% | 83 |
| DXCMDexcom | $28.11B | 31.2 | +16.1% | 76 |
| GMEDGlobus Medical | $10.85B | 18.6 | +23.5% | 76 |
| GILDGilead Sciences Inc. | $160.36B | 17.6 | +3.5% | 74 |
